Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen A Fletcher

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Tuberculosis (Edinburgh, Scotland)|September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trialsNatalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.
Plos One|August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaRoger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
Clinical and Vaccine Immunology : CVI|May 16, 2014
Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85AStephanie A Harris, Iman Satti, Magali Matsumiya, et al.
Scientific Reports|March 4, 2017
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assaysRachel Tanner, Matthew K O'Shea, Andrew D White, et al.
Scientific Reports|April 5, 2019
Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assaysRachel Tanner, Matthew K O'Shea, Andrew D White, et al.
Clinical and Vaccine Immunology : CVI|July 14, 2017
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014Michael J Brennan, Rachel Tanner, Sheldon Morris, et al.
F1000Research|October 11, 2021
The <i>in vitro</i> direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cellsRachel Tanner, Emily Hoogkamer, Julia Bitencourt, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
NPJ Vaccines|January 5, 2021
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidatesRachel Tanner, Andrew D White, Charelle Boot, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Tuberculosis (Edinburgh, Scotland)|September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trialsNatalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.
Plos One|August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaRoger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
Clinical and Vaccine Immunology : CVI|May 16, 2014
Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85AStephanie A Harris, Iman Satti, Magali Matsumiya, et al.
Scientific Reports|March 4, 2017
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assaysRachel Tanner, Matthew K O'Shea, Andrew D White, et al.
Scientific Reports|April 5, 2019
Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assaysRachel Tanner, Matthew K O'Shea, Andrew D White, et al.
Clinical and Vaccine Immunology : CVI|July 14, 2017
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014Michael J Brennan, Rachel Tanner, Sheldon Morris, et al.
F1000Research|October 11, 2021
The <i>in vitro</i> direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cellsRachel Tanner, Emily Hoogkamer, Julia Bitencourt, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
NPJ Vaccines|January 5, 2021
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidatesRachel Tanner, Andrew D White, Charelle Boot, et al.
The Journal of Infectious Diseases|June 28, 2008
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaTony Hawkridge, Thomas J Scriba, Sebastian Gelderbloem, et al.
Pageof 9